Tegaserod (Zelnorm) for Irritable Bowel Syndrome

被引：0
|
作者：
Deyoung, GR
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 2004年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：363 / 364
页数：2
相关论文
共 50 条
  • [21] Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation
    Reilly, MC
    Barghout, V
    Mcburney, CR
    Niecko, TE
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (05) : 373 - 380
  • [22] Cost-utility analysis of tegaserod for the treatment of irritable bowel syndrome
    Chen, SY
    Lin, PJ
    Biddle, AK
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A47
  • [23] Tegaserod is an effective and safe therapy for irritable bowel syndrome in a Nordic population
    Nyhlin, H
    Bang, C
    Elsborg, L
    Silvennoinen, J
    Holme, I
    Berge, M
    Rueegg, P
    Jones, J
    Wagner, A
    GASTROENTEROLOGY, 2003, 124 (04) : A389 - A389
  • [24] Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms
    Fidelholtz, J
    Smith, W
    Rawls, J
    Shi, YQ
    Zack, A
    Rüegg, P
    Lefkowitz, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (05): : 1176 - 1181
  • [25] Tegaserod maleate (zelnorm) for IBS with constipation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1139): : 79 - 80
  • [26] Case History on Tegaserod (Zelnorm®/Zelmac®)
    Giger, Rudolf
    Mattes, Henri
    Pfannkuche, Hans-Juergen
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 195 - +
  • [27] General - The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome
    McLaughlin, John
    Houghton, Lesley A.
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (02) : 313 - 327
  • [28] Tegaserod increases sigmoid accommodation in female irritable bowel syndrome (IBS) patients
    Naliboff, BD
    Chang, L
    Crowell, MD
    Holtmann, GJ
    Monnikes, H
    Lee, OY
    Schmulson, M
    Valenzuela, JE
    Stains, J
    Bolus, R
    Mayer, EA
    GASTROENTEROLOGY, 2004, 126 (04) : A101 - A101
  • [29] SAFETY AND EFFICACY OF TEGASEROD THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME OR CHRONIC CONSTIPATION
    Al-Judaibi, B.
    Chande, N.
    Gregor, J. C.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2010, 17 (01): : E194 - E200
  • [30] Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment
    李瑜元
    China Medical Abstracts(Internal Medicine), 2006, (04) : 216 - 217
12345